Bio-Techne has a market capitalization of $11.65 billion. The Zacks Consensus Estimate for the company’s fiscal 2025 earnings indicates a 5.1% year-over-year increase on a 5.5% revenue improvement. In ...

We believe that our method could greatly increase the number of recombinant proteins available for biochemical investigations. In addition, by removing the periplasmic material, a substantial ...

IL-2 Heat Stable Agonist: Engineered with enhanced thermal stability and altered receptor affinity for improved biological ...

For modern biotherapeutics, cell line development workflows must include more than just automated liquid handling.

Periplasmic protein 26 (BP26), a highly immunogenic antigen found in Brucella ... and not all serum samples were confirmed through bacterial culture. Additionally, there is a lack of comparative ...

French precision fermentation startup Standing Ovation has partnered with Ajinomoto Foods Europe to produce animal-free ...

JUPITER, Fla., Jan. 06, 2025 (GLOBE NEWSWIRE) -- (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a ...

A Danish team thinks it can aid rAAV manufacturers, who may not be able to spend three to five years working on a project ...

The life science company FUJIFILM Diosynth Biotechnologies is investing in its Hillerød site to drive the development & ...

The production of recombinant proteins and antibodies from mammalian ... platforms benefit from the use of a range of proprietary culture media, transfection reagents, expression vectors ...